Published in
Wiley, Journal of Viral Hepatitis, 2(25), p. 118-125
DOI: 10.1111/jvh.12782
Links
Tools
Efficacy and safety results of patients with HCV genotype 2 or 3 infection treated with ombitasvir/paritaprevir/ritonavir and sofosbuvir with or without ribavirin (QUARTZ II-III)
Journal article published in 2017 by
S. D. Shafran,
D. Shaw,
M. Charafeddine,
K. Agarwal 
,
G. R. Foster,
M. Abunimeh,
T. Pilot-Matias,
R. K. Pothacamury,
B. Fu,
E. Cohen,
D. E. Cohen,
E. Gane
,
G. R. Foster,
M. Abunimeh,
T. Pilot-Matias,
R. K. Pothacamury,
B. Fu,
E. Cohen,
D. E. Cohen,
E. Gane
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 